EN

Become a global leader of cellular immunotherapy.


Management Team
  • Frank Su
    Frank Su
    CEO / Co-founder
    Veteran entrepreneur, biotech investor;
    Extensive clinical development, BD experience.
  • Qi-Jing Li
    Qi-Jing Li
    Board Member / Co-founder
    Expert in TCR antigen recognition, T cell function; participated in China's first CD19 CAR-T IND.
  • Si Li
    Si Li
    CTO
    Cancer immunologist with specialization in cell engineering, gene therapy, and virology.
  • Yun Qin
    Yun Qin
    CMO
    Rich experience in clinical development.
    Has worked in several multinational and innovative pharmaceutical companies (MSD, Pfizer, AstraZeneca, and JW Therapeutics)
  • Eric Xu
    Eric Xu
    Manufacturing VP
    Extensive expertise in cellmanufacturing, technology transfer, quality control, and commercialization.
    Led manufacturing processes at multiple innovative biopharmaceutical companies, including Legend Biotech, Celgen Biopharm, Kehua Biotech, and Anke Biotech.
  • Holly Liu
    Holly Liu
    Financial Director
    Professional background in cross-industry and multi-scenario financial management;
    Diverse financial role experience in Fortune 500 companies.
  • Ling Peng
    Ling Peng
    Medical Director
    15 years of clinical oncologist;
    Rich experience in tumor immunotherapy.

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer